April 30 (Reuters) - Bubs Australia Ltd (BUB) :
- ON TRACK TO EXCEED FY24 GROUP GROSS REVENUE FORECAST
- Q3 GROUP GROSS REVENUE OF A$19.9M, UP 25.9%
- REMAINS CONFIDENT IT WILL BE CASH FLOW POSITIVE AND TRADING EBIT POSITIVE IN FY25
- Q4 FY24 GROUP GROSS REVENUE EXPECTED TO EXCEED A$30M
- CONTINUES TO FOLLOW FDA'S GUIDANCE TO OBTAIN PERMANENT ACCESS TO USA IMF MARKET
- USA IMF MARKET FDA APPROVAL EXPECTED PRIOR TO OCTOBER 2025.
- CONTINUE TO SEE STRONG DEMAND FOR OUR PRODUCTS AND BRANDS IN USA
(([email protected];))
News: BUB Bubs Australia On Track To Exceed FY24 Group Gross Revenue Forecast
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $156.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $350.0K | 2.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1303005 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 11586 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |